Understanding Diabetic Neuropathy: Focus on Oxidative Stress

Overview

Journal Oxid Med Cell Longev

Publisher Wiley

Specialties Cell Biology
Endocrinology

Date 2020 Aug 25

PMID 32832011

Citations 44

Authors

Lei Pang

Xin Lian

Huanqiu Liu

Yuan Zhang

Qian Li

Yin Cai

Haichun Ma

Xin Yu

Affiliations

Soon will be listed here.

Abstract

Diabetic neuropathy is one of the clinical syndromes characterized by pain and substantial morbidity primarily due to a lesion of the . The burden of diabetic neuropathy is related not only to the complexity of diabetes but also to the poor outcomes and difficult treatment options. There is no specific treatment for diabetic neuropathy other than glycemic control and diligent foot care. Although various metabolic pathways are impaired in diabetic neuropathy, enhanced cellular oxidative stress is proposed as a common initiator. A mechanism-based treatment of diabetic neuropathy is challenging; a better understanding of the pathophysiology of diabetic neuropathy will help to develop strategies for the new and correct diagnostic procedures and personalized interventions. Thus, we review the current knowledge of the pathophysiology in diabetic neuropathy. We focus on discussing how the defects in metabolic and vascular pathways converge to enhance oxidative stress and how they produce the onset and progression of nerve injury present in diabetic neuropathy. We discuss if the mechanisms underlying neuropathy are similarly operated in type I and type II diabetes and the progression of antioxidants in treating diabetic neuropathy.

Citing Articles

Comprehensive Assessment of Neuropathy and Metabolic Parameters in Type 1 Diabetic Patients with or Without Using Continuous Glucose Sensors.

Bordacs B, Varkonyi A, Valkusz Z, Nyiraty S, Posa A, Menyhart A Int J Mol Sci. 2025; 26(5).

PMID: 40076685 PMC: 11900075. DOI: 10.3390/ijms26052062.

Effect of high-dose N-acetyl cysteine on the clinical outcome of patients with diabetic peripheral neuropathy: a randomized controlled study.

Emara S, Fahmy S, AbdelSalam M, Wakeel L Diabetol Metab Syndr. 2025; 17(1):79.

PMID: 40038825 PMC: 11881454. DOI: 10.1186/s13098-025-01624-9.

Electroacupuncture alleviates diabetic peripheral neuropathy through modulating mitochondrial biogenesis and suppressing oxidative stress.

Yuan C, Wang X, Liu Y, Xu T, Yu Z, Xu B World J Diabetes. 2025; 16(2):93130.

PMID: 39959279 PMC: 11718478. DOI: 10.4239/wjd.v16.i2.93130.

Free radicals and their impact on health and antioxidant defenses: a review.

Chandimali N, Bak S, Park E, Lim H, Won Y, Kim E Cell Death Discov. 2025; 11(1):19.

PMID: 39856066 PMC: 11760946. DOI: 10.1038/s41420-024-02278-8.

Metabolite-Sensing Receptors: Emerging Targets for Modulating Chronic Pain Pathways.

Puscasu C, Andrei C, Olaru O, Zanfirescu A Curr Issues Mol Biol. 2025; 47(1).

PMID: 39852178 PMC: 11763455. DOI: 10.3390/cimb47010063.

References

Yao D, Taguchi T, Matsumura T, Pestell R, Edelstein D, Giardino I . High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A. J Biol Chem. 2007; 282(42):31038-45. DOI: 10.1074/jbc.M704703200. View

Du X, Edelstein D, Rossetti L, Fantus I, Goldberg H, Ziyadeh F . Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A. 2000; 97(22):12222-6. PMC: 17322. DOI: 10.1073/pnas.97.22.12222. View

Rock C, Jacob R, Bowen P . Update on the biological characteristics of the antioxidant micronutrients: vitamin C, vitamin E, and the carotenoids. J Am Diet Assoc. 1996; 96(7):693-702; quiz 703-4. DOI: 10.1016/S0002-8223(96)00190-3. View

Dyck P, Kratz K, Karnes J, Litchy W, Klein R, Pach J . The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993; 43(4):817-24. DOI: 10.1212/wnl.43.4.817. View

Fullerton B, Jeitler K, Seitz M, Horvath K, Berghold A, Siebenhofer A . Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2014; (2):CD009122. PMC: 6486147. DOI: 10.1002/14651858.CD009122.pub2. View

Vikramadithyan R, Hu Y, Noh H, Liang C, Hallam K, Tall A . Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice. J Clin Invest. 2005; 115(9):2434-43. PMC: 1190371. DOI: 10.1172/JCI24819. View

Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14):977-86. DOI: 10.1056/NEJM199309303291401. View

Martin C, Albers J, Pop-Busui R . Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care. 2013; 37(1):31-8. PMC: 3868000. DOI: 10.2337/dc13-2114. View

Vincent A, Edwards J, Sadidi M, Feldman E . The antioxidant response as a drug target in diabetic neuropathy. Curr Drug Targets. 2008; 9(1):94-100. DOI: 10.2174/138945008783431754. View

10.

Buse M . Hexosamines, insulin resistance, and the complications of diabetes: current status. Am J Physiol Endocrinol Metab. 2005; 290(1):E1-E8. PMC: 1343508. DOI: 10.1152/ajpendo.00329.2005. View

11.

Callaghan B, Kerber K, Lisabeth L, Morgenstern L, Longoria R, Rodgers A . Role of neurologists and diagnostic tests on the management of distal symmetric polyneuropathy. JAMA Neurol. 2014; 71(9):1143-9. PMC: 4266395. DOI: 10.1001/jamaneurol.2014.1279. View

12.

Vincent A, Feldman E . New insights into the mechanisms of diabetic neuropathy. Rev Endocr Metab Disord. 2004; 5(3):227-36. DOI: 10.1023/B:REMD.0000032411.11422.e0. View

13.

Kawai T, Takei I, Tokui M, Funae O, Miyamoto K, Tabata M . Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N(ɛ)-carboxymethyl lysine. J Diabetes Complications. 2009; 24(6):424-32. DOI: 10.1016/j.jdiacomp.2008.10.005. View

14.

Cheeseman K, Slater T . An introduction to free radical biochemistry. Br Med Bull. 1993; 49(3):481-93. DOI: 10.1093/oxfordjournals.bmb.a072625. View

15.

Qaseem A, Wilt T, Kansagara D, Horwitch C, Barry M, Forciea M . Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians. Ann Intern Med. 2018; 168(8):569-576. DOI: 10.7326/M17-0939. View

16.

Maritim A, Sanders R, Watkins 3rd J . Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol. 2003; 17(1):24-38. DOI: 10.1002/jbt.10058. View

17.

Kobayashi M, Zochodne D . Diabetic neuropathy and the sensory neuron: New aspects of pathogenesis and their treatment implications. J Diabetes Investig. 2018; 9(6):1239-1254. PMC: 6215951. DOI: 10.1111/jdi.12833. View

18.

Federici M, Menghini R, Mauriello A, Letizia Hribal M, Ferrelli F, Lauro D . Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells. Circulation. 2002; 106(4):466-72. DOI: 10.1161/01.cir.0000023043.02648.51. View

19.

Ziyadeh F . The extracellular matrix in diabetic nephropathy. Am J Kidney Dis. 1993; 22(5):736-44. DOI: 10.1016/s0272-6386(12)80440-9. View

20.

Pugliese G, Pricci F, Pugliese F, Mene P, Lenti L, Andreani D . Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes. 1994; 43(3):478-90. DOI: 10.2337/diab.43.3.478. View